Literature DB >> 1792905

Mitral valve prolapse in childhood: the incidence and clinical presentations in different age groups.

N Ohara1, T Mikajima, J Takagi, H Kato.   

Abstract

To elucidate the incidence and natural history of mitral valve prolapse (MVP) during childhood, we investigated a total of 4,238 children (aged from 1 day to 15 years) classified by age into 4 groups: Group 1:1 to 28-day-old full-term normal newborns (n = 108), Group 2: 6 to 18-month-old infants (n = 391), Group 3: 6 to 7-year-old children (n = 2,801), and Group 4: 12 to 15-year-old children (n = 938). The incidence of MVP was determined by videorecorded two-dimensional echocardiography in a double-blind method twice-over. There were 109 cases diagnosed as having MVP. The incidence rates of MVP were as follows: Group 1: 0%, Group 2: 0.25%, Group 3: 2.1% and Group 4: 5.1%. Arrhythmias were detected in 49% (27/55) by Holter ECG, and by exercise stress test in 4.7% (2/43). Eighty-three (77%) of 108 cases in Groups 3 and 4, excluding the 1 case in Group 2, showed no symptoms. Ventricular premature contraction (VPC) was the most common arrhythmia, and was benign in all cases. A mid-systolic click (MSC), late systolic murmur (LSM), MSC + LSM, and a pansystolic murmur were detected in 23.1%, 3.7%, 4.6% and 5.6%, respectively. Symptoms caused by MVP increased and appeared more apparently with age. Further prospective long-term follow-up studies to adulthood are necessary.

Entities:  

Mesh:

Year:  1991        PMID: 1792905     DOI: 10.1111/j.1442-200x.1991.tb02573.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  2 in total

1.  Echocardiographic screening for mitral valve prolapse in Turkish school children.

Authors:  Utku Çağlayan; Mehmet Gökhan Ramoğlu; Semra Atalay; Tayfun Uçar; Ercan Tutar
Journal:  Int J Cardiovasc Imaging       Date:  2021-01-27       Impact factor: 2.357

2.  Changing Spectrum of Cardiac Diseases in Children: An Extended Longitudinal Observation Study of a Pediatric Cardiac Screening Program.

Authors:  Chun-Min Fu; Jou-Kou Wang; Mei-Hwan Wu; Yu-Chuan Hua; Shuenn-Nan Chiu; Ming-Tai Lin; Chun-An Chen; Hung-Chi Lue
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.